封面
市场调查报告书
商品编码
1549443

美国的磁振造影(MRI)系统市场评估:磁场强度,不同设计,各用途,各终端用户,各地区,机会,预测(2017年~2031年)

United States Magnetic Resonance Imaging Systems Market Assessment, By Field Strength, By Design, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日期: | 出版商: Market Xcel - Markets and Data | 英文 135 Pages | 商品交期: 3-5个工作天内

价格

美国磁振造影 (MRI) 系统市场规模预计将从 2023 年的 18.3 亿美元增至 2031 年的 27.8 亿美元,复合年增长率预计将成长 5.38%。

MRI系统市场预计将由美国主导,这主要是由于该国快速发展和创新友好的医疗基础设施。 MRI 技术的进步正在加速美国和世界各地 MRI 系统市场的创新。影像品质和诊断准确性方面的新进展包括多参数成像、高场 MRI 扫描仪和人工智慧驱动的影像分析。此外,弥散张量造影(DTI)和功能性磁振造影(fMRI)的结合为研究大脑功能和连接性提供了新途径,从而改善了神经系统疾病的诊断和治疗。因此,老年人口的增加(更容易患神经系统疾病),加上 DTI 和 fMRI 技术的进步,预计将进一步推动 MRI 系统市场的成长。

此外,便携式和紧凑型 MRI 系统的进步正在提高这些系统在偏远地区的可及性和可用性。 Fujifilm Holdings Corporation 等全球领导者以及 Hyperfine, Inc. 和 Neuro42, Inc. 等新兴市场公司继续专注于开发紧凑型 MRI 系统。因此,技术进步和新产品推出推动了美国 MRI 系统市场的成长。例如,neuro42, Inc. 的用于神经影像应用的便携式诊断 MRI 扫描仪于 2024 年 2 月获得美国 FDA 510(k) 许可。该公司计划于 2024 年某个时候在美国市场推出该系统。

MRI 意识的提高促进市场成长

由于安装的 MRI 机器数量的增加,美国的磁振造影 (MRI) 系统市场正在扩大。由于人口老化、慢性病的增加以及准确及时诊断的需求推动了对先进诊断影像的需求,医疗机构正在大力投资 MRI 技术。现代 MRI 设备的升级功能,例如更快的扫描时间和更高解析度的影像,正在吸引医疗设施和诊断中心取代旧技术。这些发展使 MRI 服务变得更加广泛且价格实惠,有助于治疗更广泛的疾病并改善患者的治疗效果。此外,由于对非侵入性诊断方法的需求不断增加以及人们对 MRI 在疾病早期诊断方面的益处的了解不断增加,MRI 系统市场正在扩大。例如,南加州大学的研究人员在2023 年4 月进行的一项研究发表在《MDPI》(多学科数位出版研究所)杂誌上,发现许多门诊影像模式都存在延迟,包括乳房X 光摄影、MRI 、CT 模式。由于 MRI 服务急剧下降,COVID-19 大流行对此后蓬勃发展的市场产生了重大影响。

老年人口成长推动市场成长

美国 MRI 系统市场的主要成长动力之一是人口老化。随着人口老化,神经、关节和心血管疾病等与年龄相关的健康问题的盛行率也在增加。 MRI技术提供全面、非侵入性的影像,是诊断和治疗许多复杂疾病的重要工具。老年人群更有可能患有慢性疾病并需要持续护理,这使得他们更有可能需要频繁的诊断影像。因此,随着人口老化,对先进诊断设备的需求增加,推动了美国MRI系统市场的成长。美国65岁及以上人口的比例预计将从2022年的17%上升到2050年的23%。此外,65岁及以上人口预计将从2022年的5,000万增加到2050年的8,200万,成长47%。

本报告研究和分析了美国磁振造影 (MRI) 系统市场,提供市场规模和预测、市场动态以及主要参与者的现状和前景。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 摘要整理

第4章 美国的磁振造影(MRI)系统市场预测(2017年~2031年)

  • 市场规模的分析与预测
    • 金额
    • 数量
  • 市场占有率分析与预测
    • 磁场强度
    • 不同设计
    • 各用途
    • 各终端用户
    • 各地区
    • 市场占有率分析:各企业(金额)(前五名公司和其他 - 2023年)
  • 市场地图分析(2023年)
    • 磁场强度
    • 不同设计
    • 各用途
    • 各终端用户
    • 各地区

第5章 供需分析

第6章 进口和出口的分析

第7章 价值链分析

第8章 波特的五力分析

第9章 大环境分析

第10章 价格分析

第11章 市场动态

  • 推动市场要素
  • 市场课题

第12章 市场趋势与发展

第13章 法规结构和革新

  • 法规当局的认证

第14章 专利形势

第15章 案例研究

第16章 竞争情形

  • 市场领导者前五名公司的竞争矩阵
  • 前五名公司的SWOT分析
  • 主要企业前十大企业的形势
    • GE Healthcare Technologies Inc.
    • Canon Medical Systems Corporation
    • Koninklijke Philips N.V.
    • Siemens Healthineers AG
    • Aurora Healthcare US Corp.
    • Fujifilm Holdings Corporation
    • Neusoft Medical Systems Co. Ltd.
    • Bruker Corporation
    • United Imaging Healthcare Co., Ltd.
    • Fonar Corporation

第17章 策略性推荐

第18章 本公司相关资料,免责声明

Product Code: MX11874

United States magnetic resonance imaging (MRI) systems market is projected to witness a CAGR of 5.38% during the forecast period 2024-2031, growing from USD 1.83 billion in 2023 to USD 2.78 billion in 2031.

The MRI systems market is expected to dominate in the United States mainly because of its fast-paced development and innovation-friendly healthcare infrastructure. Innovation in the MRI systems market has accelerated in the United States as well as globally due to advancements in MRI technologies. New advancements in image quality and diagnostic precision include multi-parametric imaging, higher-field MRI scanners, and AI-driven image analysis. In addition, new avenues for studying brain function and connectivity have been made possible by the combination of diffusion tensor imaging (DTI) and functional magnetic resonance imaging (fMRI), which has improved neurological disease diagnosis and treatment. Thus, the rising geriatric population, which is more prone to developing neurological disorders coupled with advancements in DTI and fMRI technologies, is expected further to fuel the growth of MRI systems in the market.

Furthermore, advancements in portable and compact MRI systems have improved the access and availability of these systems in remote areas. Global leaders, such as Fujifilm Holdings Corporation, and emerging market players, such as Hyperfine, Inc., and neuro42, Inc., continuously focus on developing compact MRI systems. Thus, technological advancements and new product launches will accelerate the growth of the United States MRI systems market. For instance, in February 2024, neuro42, Inc. received US FDA 510(k) clearance for its portable diagnostic MRI scanner for neuroimaging applications. The company is planning to launch this system in the US market during year 2024.

Rising Awareness About MRIs Drive Market Growth

The magnetic resonance imaging (MRI) systems market in the United States is expanding due to the growing installation of MRI machines. Healthcare facilities are heavily investing in MRI technology as demand for advanced diagnostic imaging is rising due to an aging population, an increase in chronic diseases, and the need for accurate and timely diagnosis. The upgraded features of contemporary MRI machines, such as faster scanning periods and higher resolution images, are drawing medical facilities and diagnostic centers to replace their outdated technology. These developments make MRI services more widely available and reasonably priced, treating a wider spectrum of illnesses and enhancing patient outcomes. In addition, the MRI systems market is expanding due to rising demand for non-invasive diagnostic methods and growing knowledge of the advantages of MRI in early disease diagnosis. For example, a study conducted in April 2023 and published in the Multidisciplinary Digital Publishing Institute (MDPI) journal by researchers at the University of Southern California found that delays were observed in many imaging modalities in the outpatient setting, with the modalities of mammography, MRI, and CT showing the largest decreases with over 12,000 imaging delays. Due to the sharp decline in MRI services, the COVID-19 pandemic thus had a major effect on the market and has only flourished ever since then.

Rising Geriatric Population Boosts Market Growth

One major factor propelling the growth of the MRI systems market in the United States is the aging population. The prevalence of age-related health concerns, including neurological illnesses, joint problems, and cardiovascular conditions, is rising along with the elderly population. With its comprehensive and non-invasive imaging capabilities, MRI technology is a vital tool in the diagnosis and treatment of many intricate disorders. Since they are more likely to have chronic illnesses and need ongoing care, older persons are more likely to need frequent diagnostic imaging. Thus, in turn, the aging population is driving an increased demand for advanced diagnostic instruments, which is driving the growth of the MRI systems market in the United States. The population share of the United States, which constitutes people aged 65 and above, is projected to rise from 17% in 2022 to 23% by 2050. Moreover, the number of people aged 65 and above is expected to rise from 50 million in 2022 to 82 million in 2050, showcasing a hike of 47%.

Dominance of High Field Strength MRI Segment in the United State MRI Systems Market

The magnetic resonance imaging (MRI) systems market in the United States is expanding at a substantial rate due to the introduction of high-field strength (HF) and ultra-high field strength (UH) MRI systems. Compared to conventional 1.5T MRI machines, HF MRI systems, which commonly operate at 3 Tesla (T), and UH MRI systems, which operate at 7T and beyond, offer improved imaging capabilities. These cutting-edge devices enable earlier and more accurate diagnosis of a variety of illnesses by improving image contrast, resolution, and detail. Since high-field strength MRI systems can record fine anatomical and physiological features, which are essential for diagnosing complicated neurological, musculoskeletal, and cardiovascular problems, they are gaining increasing traction and widespread adoption. For instance, in March 2024, Siemens Healthineers AG announced the launch of MAGNETOM Terra.X. This second-generation clinical 7-tesla magnetic resonance imaging scanner significantly improves 7T MR scanning capabilities with new hardware and XA60A software, which has also received FDA certification. The MAGNETOM Terra, which made its debut in 2017 as the first 7T clinical MR scanner in the world and allowed incredibly high-resolution imaging, is now replaced by the MAGNETOM Terra.X.

Neurology Segment Dominates United States Magnetic Resonance Imaging (MRI) Systems Market

MRI systems are utilized to obtain fine-grained images of the bones, organs, tissues, and nerves in the body. MRI is used to diagnose several conditions, including stroke, traumatic brain injury, brain and spinal cord tumors, inflammation, infection, vascular abnormalities, brain damage connected to epilepsy, abnormally formed brain regions, and other neurodegenerative illnesses. Due to the growing use of MRI imaging in the diagnosis of neurological diseases and the development of sophisticated MRI equipment for neurology, the neurology segment of the market is anticipated to rise significantly. Additionally, it is anticipated that the rise in neurological conditions like dementia and Alzheimer's disease will increase demand for MRI machines in the US, which will support the market's expansion throughout the projected period. For instance, the Alzheimer's Disease Facts and Figures study estimated that 6.7 million Americans, 65 years of age and older, were diagnosed with Alzheimer's dementia in 2023. Furthermore, it is anticipated that by 2050, 12.7 million of the population would be suffering from dementia in the United States.

Future Market Scenario (2024-2031F)

The main factors contributing to the anticipated growth of the United States magnetic resonance imaging (MRI) systems market are the rising numbers of chronic ailments, the increasing prevalence of diseases, and thus, the rising requirement to conduct diagnostic tests. However, the growing need to have precision medicine to maintain a healthy population is also going to fuel the MRI Systems market growth in the future. Given that technology is advancing, cutting-edge technology in the area is expected. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, in October 2023, Koninklijke Philips N.V. announced its collaboration with Quibim to introduce advanced AI-driven imaging software aimed at prostate cancer detection. By combining Philips' innovative AI-enhanced MR imaging software with Quibim's AI-powered image analysis software, healthcare providers can expedite and simplify prostate cancer diagnosis and care.

Key Players Landscape and Outlook

The United States MRI systems market is a consolidated market with the majority of the share held by global leaders, including GE Healthcare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Fujifilm Holdings Corporation, and Canon Inc. These players are complying with new strategic initiatives regarding the launches of newly developed magnetic resonance imaging techniques to help researchers and to strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.

For example, in September 2023, an agreement in the field of MRI was signed by Subtle Medical, Inc., an artificial intelligence (AI)-powered image acquisition solution provider, and Bracco Imaging S.p.A., a manufacturer of diagnostic imaging components. These international collaborations were anticipated to start in the United States, where Bracco Imaging most likely uses Bracco Diagnostics Inc., a subsidiary, to distribute its line of goods and services.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. United States Magnetic Resonance Imaging (MRI) Systems Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Field Strength
      • 4.2.1.1. Low
      • 4.2.1.2. Medium
      • 4.2.1.3. High
      • 4.2.1.4. Ultra-High
    • 4.2.2. By Design
      • 4.2.2.1. Open MRI
      • 4.2.2.2. Traditional MRI
      • 4.2.2.3. Wide Bore MRI
    • 4.2.3. By Application
      • 4.2.3.1. Cardiology
      • 4.2.3.2. Oncology
      • 4.2.3.3. Neurology
      • 4.2.3.4. Musculoskeletal
      • 4.2.3.5. Orthopedic
      • 4.2.3.6. Gastroenterology
      • 4.2.3.7. Others
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals
      • 4.2.4.2. Diagnostic and Imaging Centers
      • 4.2.4.3. Ambulatory Surgical Centers
      • 4.2.4.4. Others
    • 4.2.5. By Region
      • 4.2.5.1. Northeast
      • 4.2.5.2. Midwest
      • 4.2.5.3. West
      • 4.2.5.4. South
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Field Strength
    • 4.3.2. By Design
    • 4.3.3. By Application
    • 4.3.4. By End-user
    • 4.3.5. By Region

All segments will be provided for all regions and countries covered

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

  • 11.1. Market Drivers
  • 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

  • 13.1. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

  • 16.1. Competition Matrix of Top 5 Market Leaders
  • 16.2. SWOT Analysis for Top 5 Players
  • 16.3. Key Players Landscape for Top 10 Market Players
    • 16.3.1. GE Healthcare Technologies Inc.
      • 16.3.1.1. Company Details
      • 16.3.1.2. Key Management Personnel
      • 16.3.1.3. Products and Services
      • 16.3.1.4. Financials (As Reported)
      • 16.3.1.5. Key Market Focus and Geographical Presence
      • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 16.3.2. Canon Medical Systems Corporation
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Siemens Healthineers AG
    • 16.3.5. Aurora Healthcare US Corp.
    • 16.3.6. Fujifilm Holdings Corporation
    • 16.3.7. Neusoft Medical Systems Co. Ltd.
    • 16.3.8. Bruker Corporation
    • 16.3.9. United Imaging Healthcare Co., Ltd.
    • 16.3.10. Fonar Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. United States Magnetic Resonance Imaging Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. United States Magnetic Resonance Imaging Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. United States Magnetic Resonance Imaging Systems Market Share (%), By Field Strength, 2017-2031F
  • Figure 4. United States Magnetic Resonance Imaging Systems Market Share (%), By Design, 2017-2031F
  • Figure 5. United States Magnetic Resonance Imaging Systems Market Share (%), By Application, 2017-2031F
  • Figure 6. United States Magnetic Resonance Imaging Systems Market Share (%), By End-user, 2017-2031F
  • Figure 7. United States Magnetic Resonance Imaging Systems Market Share (%), By Region, 2017-2031F
  • Figure 8. By Field Strength Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 9. By Design Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 10. By Application Size Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 11. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 12. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023